Stay updated on HMPL-523 in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HMPL-523 in Hematologic Malignancies Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:02:05.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the dosage or characterization of dose limited toxicities associated with HMPL-523 administered to patients with relapsed or refractory Hematologic Malignancies in a Phase I study.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:27.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value '6' has been updated to a disclaimer stating that the U.S. government does not review or approve the safety and science of all studies listed on the website. Additionally, the status of the study 'A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies' has been changed to 'Unknown status'.
    Difference
    100%
    Check dated 2024-05-22T20:31:22.000Z thumbnail image
  8. Check
    26 days ago
    Change Detected
    Summary
    The value on the webpage has recently changed to an unknown status. This change may indicate a potential update or revision related to medical and healthcare-related publications and documentation.
    Difference
    79%
    Check dated 2024-05-21T12:38:02.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T23:16:33.000Z thumbnail image

Stay in the know with updates to HMPL-523 in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.